title: [The reactogenic properties and antigenic activity of inactivated 3-component influenza vaccines used intranasally].
authors.forename: M K
authors.initials: MK
authors.lastname: Erofeeva
authors.forename: V L
authors.initials: VL
authors.lastname: Maksakova
authors.forename: A A
authors.initials: AA
authors.lastname: Mikhaĭlov
authors.forename: N V
authors.initials: NV
authors.lastname: Kostiuchek
authors.forename: I G
authors.initials: IG
authors.lastname: Marinich
authors.forename: I M
authors.initials: IM
authors.lastname: Tsaritsyna
authors.forename: A S
authors.initials: AS
authors.lastname: Shadrin
authors.forename: T I
authors.initials: TI
authors.lastname: Subbotina
authors.forename: L V
authors.initials: LV
authors.lastname: Sidorova
authors.forename: E M
authors.initials: EM
authors.lastname: Voĭtsekhovskaia
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D000918:Antibody Specificity; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000097:blood; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D007071:Immunoglobulin A, Secretory; D007252:Influenza Vaccines; D017778:Vaccines, Combined; D015164:Vaccines, Inactivated
vernacular_title: Reaktogennye svoĭstva i antigennaia aktivnost' inaktivirovannykh trekhkomponentnykh grippoznykh vaktsin pri intranazal'nom primenenii.